Cite
HARVARD Citation
Shortt, J. et al. (n.d.). P590: PRELIMINARY SAFETY AND EFFICACY OF BGB-11417, A POTENT AND SELECTIVE B-CELL LYMPHOMA 2 (BCL2) INHIBITOR, IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML). HemaSphere. pp. 489-490. [Online].